Risk of Bias ≤6; Current Metformin Use Vs. No Current Metformin Use in Western-Based Case-Controls Studies. Comparison of metformin use in Western-based case-control studies with a Newcastle-Ottawa score ≤ 6. (DOCX 19 kb
Table S2. Multivariate regression analysis for disease specific survival (DSS) in patients taking me...
Background This study aims to examine the associations between metformin use concurrent with androg...
The aim of this study was to compare the risks of new-onset prostate cancer between metformin and su...
Risk of Bias ≤6; Current Metformin Use Vs. No Current Metformin Use in Western- and Asian-Based Case...
Risk of Bias ≤6; Current Metformin Use Vs. No Current Metformin Use in Asian Based Case-Control Stud...
Risk of Bias ≤6; Current Metformin Use Vs. No Current Metformin Use in Western- and Asian-Based Coho...
Current Metformin Use Vs. No Current Metformin Use in Western- and Asian-Based Cohort Studies. Compa...
Current Metformin Use Vs. No Current Metformin Use in Asian-Based Observational Studies. Comparison ...
Current Metformin Use Vs. No Current Metformin Use in Asian-Based Case-Control Studies. Comparison o...
Abstract Background Metformin is associated with a reduced risk of some cancers but its effect on pr...
Purpose Metformin is a commonly used medication for type II diabetes mellitus. Epidemiologic studies...
Background: The aim of this study was to compare the risks of new-onset prostate cancer between metf...
Background: Several in vitro studies have indicated that metformin may reduce the risk of prostate c...
[[abstract]]BACKGROUND: Whether metformin therapy affects incident prostate cancer risk in Asian pat...
Background: This thesis is composed of three studies. In the first paper, we tested the association ...
Table S2. Multivariate regression analysis for disease specific survival (DSS) in patients taking me...
Background This study aims to examine the associations between metformin use concurrent with androg...
The aim of this study was to compare the risks of new-onset prostate cancer between metformin and su...
Risk of Bias ≤6; Current Metformin Use Vs. No Current Metformin Use in Western- and Asian-Based Case...
Risk of Bias ≤6; Current Metformin Use Vs. No Current Metformin Use in Asian Based Case-Control Stud...
Risk of Bias ≤6; Current Metformin Use Vs. No Current Metformin Use in Western- and Asian-Based Coho...
Current Metformin Use Vs. No Current Metformin Use in Western- and Asian-Based Cohort Studies. Compa...
Current Metformin Use Vs. No Current Metformin Use in Asian-Based Observational Studies. Comparison ...
Current Metformin Use Vs. No Current Metformin Use in Asian-Based Case-Control Studies. Comparison o...
Abstract Background Metformin is associated with a reduced risk of some cancers but its effect on pr...
Purpose Metformin is a commonly used medication for type II diabetes mellitus. Epidemiologic studies...
Background: The aim of this study was to compare the risks of new-onset prostate cancer between metf...
Background: Several in vitro studies have indicated that metformin may reduce the risk of prostate c...
[[abstract]]BACKGROUND: Whether metformin therapy affects incident prostate cancer risk in Asian pat...
Background: This thesis is composed of three studies. In the first paper, we tested the association ...
Table S2. Multivariate regression analysis for disease specific survival (DSS) in patients taking me...
Background This study aims to examine the associations between metformin use concurrent with androg...
The aim of this study was to compare the risks of new-onset prostate cancer between metformin and su...